4
Changes in Ownership
CytomX Therapeutics, Inc. Filed Acc 0001140361-17-027295
Chief Financial Officer sold 2,500 shares at $15.47 ($38,675)
From the SEC's structured data for this filing
Trades in this filing
RAY DEBANJAN · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2017-07-03 | Sale : show line 1 in the form | −2,500 | $15.47 | $38,675 | 22,126 | D |
| Open-market sales · 2,500 sh · avg $15.47 · $38,675 | ||||||
Loading xslF345X03/doc1.xml…